Madrigal Pharmaceuticals Stock (NASDAQ: MDGL) stock price, news, charts, stock research, profile.
Open | $243.47 |
Close | $233.49 |
Volume / Avg. | 530.02K / 282.06K |
Day Range | $233.00 - $244.23 |
52 Wk Range | 119.76 - 299.98 |
Market Cap | $5.07B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 24.89% |
Days to Cover | 20 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.
Other companies in Madrigal Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
Madrigal Pharmaceuticals has a consensus price target of $331.13.
The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $233.49 last updated September 20, 2024 at 4:39 PM EDT.
There are no upcoming dividends for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.